BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $735,449 | -24.7% | 30,580 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $976,419 | +12.6% | 30,580 | +7.9% | 0.00% | 0.0% |
| Q1 2023 | $867,465 | -13.1% | 28,330 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $998,478 | +52.7% | 25,530 | +85.9% | 0.00% | 0.0% |
| Q3 2022 | $654,000 | -77.3% | 13,730 | -81.6% | 0.00% | -71.4% |
| Q2 2022 | $2,884,000 | +495.9% | 74,487 | +782.5% | 0.01% | +600.0% |
| Q1 2022 | $484,000 | -28.1% | 8,440 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $673,000 | -71.4% | 8,440 | -68.8% | 0.00% | -80.0% |
| Q3 2021 | $2,353,000 | -32.4% | 27,034 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $3,480,000 | +60.8% | 27,034 | 0.0% | 0.01% | +40.0% |
| Q1 2021 | $2,164,000 | -78.0% | 27,034 | -77.5% | 0.01% | -77.3% |
| Q4 2020 | $9,821,000 | +506.6% | 120,307 | +82.8% | 0.02% | +450.0% |
| Q3 2020 | $1,619,000 | +103.1% | 65,818 | +131.3% | 0.00% | +100.0% |
| Q2 2020 | $797,000 | +27.9% | 28,452 | -17.8% | 0.00% | 0.0% |
| Q1 2020 | $623,000 | – | 34,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |